Navigation Links
Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACC's 57th Annual Scientific Session
Date:3/26/2008

Presentation by Leader of Innovative Scripps Genomic Medicine Program to

Include Data on Novel Genomic Markers for Cardiac Disease

SAN DIEGO, March 26 /PRNewswire/ -- Eric J. Topol, M.D., chief academic officer of Scripps Health and director of the Scripps Translational Science Institute, will present a late-breaking lecture about advancements in the genomics of cardiovascular disease at the American College of Cardiology's (ACC) 57th Annual Scientific Session in Chicago.

Dr. Topol's presentation on March 31 will include data concerning new, compelling genomic markers for myocardial infarction, coronary artery disease, atrial fibrillation and abnormal lipoproteins. A panel discussion about the progress, limitations, caveats and future issues in cardiovascular genomic medicine will follow the presentation.

Who: Eric J. Topol, M.D., Chief Academic Officer, Scripps Health;

Director of Scripps Translational Science Institute; Professor of

Translational Genomics, The Scripps Research Institute

What: Late-breaking lecture about advancements in the genomics of

cardiovascular disease

When: 3:30 p.m.-4:30 p.m. CDT, March 31

Where: North Hall B1, McCormick Place, Chicago

About Scripps Genomic Medicine

An initiative of Scripps Health and The Scripps Research Institute, Scripps Genomic Medicine is an innovative program in which genomic researchers, clinicians and other specialists are working side-by-side to advance medicine. Current projects include the genotyping of tens of thousands of individuals of diverse ancestry to identify and define genes that are responsible for major disease and the underpinnings of health. Through The Scripps Translational Science Institute, this basic research will be translated into drug discovery programs and, ultimately, clinical trials. These trials, launched through Scripps Advanced Clinical Trials, will test individualized treatment and prevention strategies in collaboration with pharmaceutical, medical device, biotechnology and diagnostic companies. For more information, visit http://www.scrippshealth.org/genomic.

About Scripps Health

Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps Health is a non-profit community health system based in San Diego. Scripps treats a half-million patients annually through the dedication of 2,600 affiliated physicians and 11,000 employees among its five acute-care hospital campuses, home health care services, and an ambulatory care network of clinics, physician offices and outpatient centers. Recognized as a national leader in the prevention, diagnosis, and treatment of disease, Scripps is also at the forefront of clinical research and graduate medical education. For more information, visit http://www.scrippshealth.org.


'/>"/>
SOURCE Scripps Health
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Charles A. Peck, M.D., F.A.C.P. Joins LifeMasters as New Medical Director Focused on Client Experience
4. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
5. William F. Balistreri, M.D., honored with Distinguished Service Award by AASLD
6. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
7. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
8. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
9. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
11. AtriCure to Present at Roth Capital Partners 2007 New York Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® ... area” Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony ... Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ...
(Date:12/4/2016)... Washington DC (PRWEB) , ... December 04, 2016 , ... ... Environmental, one of the most certified and experienced Indoor Air Quality Companies in VA, ... Assessment and Remediation Regulations. , The new mold law in the district ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: